|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - G1 Therapeutics Inc. (GTHX)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-12-26 Purchase |
2018-12-27 4:59 pm |
G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel |
1,000 | $18.25 | $18,250 | 3,000 (Direct) |
View |
| 2018-12-26 Purchase |
2018-12-27 4:59 pm |
G1 Therapeutics Inc. | GTHX | Schwalm Cynthia Director |
1,420 | $18.45 | $26,196 | 1,500 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-17 4:27 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
3,776 | $30 | $113,280 | 65,519 (Direct) |
View |
| 2018-12-10 Purchase |
2018-12-11 4:08 pm |
G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel |
1,000 | $32.51 | $32,508 | 2,000 (Direct) |
View |
| 2018-12-10 Purchase |
2018-12-11 4:08 pm |
G1 Therapeutics Inc. | GTHX | DEMAREE JOHN Chief Commercial Officer |
1,000 | $33.15 | $33,151 | 5,250 (Direct) |
View |
| 2018-12-06 Sale |
2018-12-07 4:07 pm |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
750 | $34 | $25,500 | 10,333 (Direct) |
View |
| 2018-12-04 Sale |
2018-12-04 6:10 pm |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
10,000 | $39.31 | $393,146 | 58,282 (Indirect Direct) |
View |
| 2018-12-03 Sale |
2018-12-03 6:25 pm |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L VP |
3,523 | $38.54 | $135,779 | 82,401 (Direct) |
View |
| 2018-11-15 Sale |
2018-11-16 7:16 pm |
G1 Therapeutics Inc. | GTHX | PHILLIPS BARCLAY A CFO |
5,000 | $39.92 | $199,591 | 95,000 (Direct) |
View |
| 2018-11-15 Sale |
2018-11-16 5:17 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
5,000 | $39.84 | $199,211 | 119,433 (Direct) |
View |
| 2018-11-15 Sale |
2018-11-16 5:17 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
3,776 | $39.75 | $150,105 | 69,295 (Direct) |
View |
| 2018-11-05 Sale |
2018-11-07 6:18 pm |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
10,000 | $41.53 | $415,347 | 58,282 (Indirect Direct) |
View |
| 2018-11-05 Sale |
2018-11-07 6:18 pm |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L VP |
3,519 | $41.53 | $146,129 | 85,924 (Direct) |
View |
| 2018-11-05 Sale |
2018-11-07 6:15 pm |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
750 | $41.38 | $31,035 | 2,750 (Direct) |
View |
| 2018-10-15 Sale |
2018-10-15 5:57 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
3,776 | $41.71 | $157,497 | 97,444 (Direct) |
View |
| 2018-10-11 Sale |
2018-10-15 5:54 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
5,000 | $41.53 | $207,645 | 389,286 (Direct) |
View |
| 2018-10-08 Sale |
2018-10-10 4:45 pm |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
750 | $44.52 | $33,390 | 3,166 (Direct) |
View |
| 2018-10-04 Sale |
2018-10-05 6:02 pm |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
10,000 | $49.72 | $497,210 | 58,282 (Indirect Direct) |
View |
| 2018-10-03 Sale |
2018-10-05 6:02 pm |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L VP |
3,519 | $49.18 | $173,064 | 89,443 (Direct) |
View |
| 2018-09-17 Sale |
2018-09-19 7:08 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
5,000 | $66.31 | $331,549 | 129,433 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-06-12 Option Award |
2019-06-14 4:38 pm |
N/A 2029-06-12 |
G1 Therapeutics Inc. | GTHX | ESHELMAN FREDRIC N Director |
20,000 | $18.47 | 20,000 (Direct) |
View |
| 2019-06-12 Option Award |
2019-06-14 4:36 pm |
N/A 2029-06-12 |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
20,000 | $18.47 | 20,000 (Direct) |
View |
| 2019-06-12 Option Award |
2019-06-14 4:35 pm |
N/A 2029-06-12 |
G1 Therapeutics Inc. | GTHX | Deese Willie A Director |
20,000 | $18.47 | 20,000 (Direct) |
View |
| 2019-06-12 Option Award |
2019-06-14 4:33 pm |
N/A 2029-06-12 |
G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director |
20,000 | $18.47 | 100,000 (Direct) |
View |
| 2019-06-12 Option Award |
2019-06-14 4:33 pm |
N/A 2029-06-12 |
G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director |
100,000 | $18.47 | 100,000 (Direct) |
View |
| 2019-06-12 Option Award |
2019-06-14 4:32 pm |
N/A 2029-06-12 |
G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director |
20,000 | $18.47 | 20,000 (Direct) |
View |
| 2019-06-12 Option Award |
2019-06-14 4:31 pm |
N/A 2029-06-12 |
G1 Therapeutics Inc. | GTHX | Schwalm Cynthia Director |
20,000 | $18.47 | 20,000 (Direct) |
View |
| 2019-06-12 Option Award |
2019-06-14 4:30 pm |
N/A 2029-06-12 |
G1 Therapeutics Inc. | GTHX | WITTY ANDREW Director |
20,000 | $18.47 | 20,000 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:26 pm |
N/A 2029-05-08 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
50,000 | $20.91 | 50,000 (Direct) |
View |
| 2019-01-28 Exercise |
2019-01-28 9:10 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
7,000 | $0.39 | 90,444 (Direct) |
View |
| 2019-01-28 Exercise |
2019-01-28 9:10 pm |
N/A 2024-07-11 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
7,000 | $0.39 | 90,444 (Direct) |
View |
| 2019-01-17 Exercise |
2019-01-17 5:52 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
2,000 | $3.72 | 8,333 (Direct) |
View |
| 2019-01-17 Exercise |
2019-01-17 5:52 pm |
N/A 2025-12-21 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
2,000 | $3.72 | 8,333 (Direct) |
View |
| 2019-01-17 Exercise |
2019-01-17 5:52 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
9,000 | $0.39 | 380,286 (Direct) |
View |
| 2019-01-17 Exercise |
2019-01-17 5:52 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
9,000 | $0.39 | 380,286 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-02 5:46 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer |
39,485 | $0.3 | 129,237 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-02 5:46 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer |
40,333 | $0.39 | 129,237 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-02 5:46 pm |
N/A 2029-01-02 |
G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer |
15,000 | $19.56 | 129,237 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-02 5:46 pm |
N/A 2024-01-21 |
G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer |
13,333 | $0.39 | 129,237 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-02 5:46 pm |
N/A 2024-07-11 |
G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer |
27,000 | $0.39 | 129,237 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-02 5:46 pm |
N/A 2022-11-09 |
G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer |
15,816 | $0.3 | 129,237 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-02 5:46 pm |
N/A 2023-01-09 |
G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer |
10,336 | $0.3 | 129,237 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-02 5:46 pm |
N/A 2023-04-16 |
G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer |
13,333 | $0.3 | 129,237 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-02 5:32 pm |
N/A 2029-01-02 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
20,000 | $19.56 | 20,000 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-02 5:29 pm |
N/A 2029-01-02 |
G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel |
60,000 | $19.56 | 60,000 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-02 5:29 pm |
N/A 2029-01-02 |
G1 Therapeutics Inc. | GTHX | PHILLIPS BARCLAY A CFO |
60,000 | $19.56 | 60,000 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-02 5:29 pm |
N/A 2029-01-02 |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L COO |
60,000 | $19.56 | 60,000 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-02 5:29 pm |
N/A 2029-01-02 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
60,000 | $19.56 | 60,000 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-02 5:28 pm |
N/A 2029-01-02 |
G1 Therapeutics Inc. | GTHX | DEMAREE JOHN Chief Commercial Officer |
60,000 | $19.56 | 60,000 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-02 5:28 pm |
N/A 2029-01-02 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
225,000 | $19.56 | 225,000 (Direct) |
View |
| 2018-12-17 Exercise |
2018-12-17 4:27 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
3,776 | $4.17 | 65,519 (Direct) |
View |
| 2018-12-17 Exercise |
2018-12-17 4:27 pm |
N/A 2026-05-10 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
3,776 | $4.17 | 65,519 (Direct) |
View |
| 2018-12-06 Exercise |
2018-12-07 4:07 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
750 | $0.39 | 10,333 (Direct) |
View |
| 2018-12-06 Exercise |
2018-12-07 4:07 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
2,000 | $3.72 | 10,333 (Direct) |
View |
| 2018-12-06 Exercise |
2018-12-07 4:07 pm |
N/A 2024-07-11 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
750 | $0.39 | 10,333 (Direct) |
View |
| 2018-12-06 Exercise |
2018-12-07 4:07 pm |
N/A 2025-12-21 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
2,000 | $3.72 | 10,333 (Direct) |
View |
| 2018-12-04 Exercise |
2018-12-04 6:10 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
607 | $0.39 | 58,282 (Direct) |
View |
| 2018-12-04 Exercise |
2018-12-04 6:10 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
9,393 | $0.39 | 58,282 (Direct) |
View |
| 2018-12-04 Exercise |
2018-12-04 6:10 pm |
N/A 2024-01-21 |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
607 | $0.39 | 58,282 (Direct) |
View |
| 2018-12-04 Exercise |
2018-12-04 6:10 pm |
N/A 2024-07-11 |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
9,393 | $0.39 | 58,282 (Direct) |
View |
| 2018-12-03 Exercise |
2018-12-03 6:25 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L VP |
3,523 | $13.51 | 82,401 (Direct) |
View |
| 2018-12-03 Exercise |
2018-12-03 6:25 pm |
N/A 2027-08-01 |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L VP |
3,523 | $13.51 | 82,401 (Direct) |
View |
| 2018-11-15 Exercise |
2018-11-16 7:16 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | PHILLIPS BARCLAY A CFO |
5,000 | $19.46 | 95,000 (Direct) |
View |
| 2018-11-15 Exercise |
2018-11-16 7:16 pm |
N/A 2027-12-06 |
G1 Therapeutics Inc. | GTHX | PHILLIPS BARCLAY A CFO |
5,000 | $19.46 | 95,000 (Direct) |
View |
| 2018-11-15 Exercise |
2018-11-16 5:17 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
5,000 | $3.72 | 119,433 (Direct) |
View |
| 2018-11-15 Exercise |
2018-11-16 5:17 pm |
N/A 2025-12-21 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
5,000 | $3.72 | 119,433 (Direct) |
View |
| 2018-11-15 Exercise |
2018-11-16 5:17 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
3,776 | $4.17 | 69,295 (Direct) |
View |
| 2018-11-15 Exercise |
2018-11-16 5:17 pm |
N/A 2026-05-10 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
3,776 | $4.17 | 69,295 (Direct) |
View |
| 2018-11-05 Exercise |
2018-11-07 6:18 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
10,000 | $0.39 | 58,282 (Direct) |
View |
| 2018-11-05 Exercise |
2018-11-07 6:18 pm |
N/A 2024-01-21 |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
10,000 | $0.39 | 58,282 (Direct) |
View |
| 2018-11-05 Exercise |
2018-11-07 6:18 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L VP |
3,519 | $13.51 | 85,924 (Direct) |
View |
| 2018-11-05 Exercise |
2018-11-07 6:18 pm |
N/A 2027-08-01 |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L VP |
3,519 | $13.51 | 85,924 (Direct) |
View |
| 2018-11-05 Exercise |
2018-11-07 6:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
750 | $0.39 | 2,750 (Direct) |
View |
| 2018-11-05 Exercise |
2018-11-07 6:15 pm |
N/A 2024-07-11 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
750 | $0.39 | 2,750 (Direct) |
View |
| 2018-10-15 Exercise |
2018-10-15 5:57 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
3,776 | $4.17 | 97,444 (Direct) |
View |
| 2018-10-15 Exercise |
2018-10-15 5:57 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
6,300 | $0.39 | 97,444 (Direct) |
View |
| 2018-10-15 Exercise |
2018-10-15 5:57 pm |
N/A 2026-05-10 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
3,776 | $4.17 | 97,444 (Direct) |
View |
| 2018-10-15 Exercise |
2018-10-15 5:57 pm |
N/A 2024-07-11 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh VP |
6,300 | $0.39 | 97,444 (Direct) |
View |
| 2018-10-11 Exercise |
2018-10-15 5:54 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
10,000 | $0.39 | 389,286 (Direct) |
View |
| 2018-10-11 Exercise |
2018-10-15 5:54 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
5,000 | $3.72 | 389,286 (Direct) |
View |
| 2018-10-11 Exercise |
2018-10-15 5:54 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
10,000 | $0.39 | 389,286 (Direct) |
View |
| 2018-10-11 Exercise |
2018-10-15 5:54 pm |
N/A 2025-12-21 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
5,000 | $3.72 | 389,286 (Direct) |
View |
| 2018-10-08 Exercise |
2018-10-10 4:45 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
750 | $0.39 | 3,166 (Direct) |
View |
| 2018-10-08 Exercise |
2018-10-10 4:45 pm |
N/A 2024-07-11 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP |
750 | $0.39 | 3,166 (Direct) |
View |
| 2018-10-04 Exercise |
2018-10-05 6:04 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer |
850 | $0.3 | 49,419 (Direct) |
View |
| 2018-10-04 Exercise |
2018-10-05 6:04 pm |
N/A 2022-11-09 |
G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer |
850 | $0.3 | 49,419 (Direct) |
View |
| 2018-10-04 Exercise |
2018-10-05 6:02 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
10,000 | $0.39 | 58,282 (Direct) |
View |
| 2018-10-04 Exercise |
2018-10-05 6:02 pm |
N/A 2024-01-21 |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
10,000 | $0.39 | 58,282 (Direct) |
View |
| 2018-10-03 Exercise |
2018-10-05 6:02 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L VP |
3,519 | $13.51 | 89,443 (Direct) |
View |
| 2018-10-03 Exercise |
2018-10-05 6:02 pm |
N/A 2027-08-01 |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L VP |
3,519 | $13.51 | 89,443 (Direct) |
View |
| 2018-09-17 Exercise |
2018-09-19 7:08 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
5,000 | $3.72 | 129,433 (Direct) |
View |
| 2018-09-17 Exercise |
2018-09-19 7:08 pm |
N/A 2025-12-21 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO |
5,000 | $3.72 | 129,433 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 20 Jun 2019 09:00:49 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |